Astrazeneca Lp. v. Mylan Pharmaceuticals Inc.

• Court: Court of Appeals for the Federal Circuit
• Decided: April 9, 2012
• Docket: 2011-1506
• Status: Unpublished

Opinion

NOTE: This disposition is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________

ASTRAZENECA LP, AKTIEBOLAGET DRACO, KBI INC., AND KBI-E INC., Plaintiffs-Appellants,

v.

MYLAN PHARMACEUTICALS INC., Defendant-Appellee. ____________________

2011-1506 ______________________

Appeal from the United States District Court for the District of Delaware in No. 08-CV-0453, Chief Judge Gregory M. Sleet. ______________________

JUDGMENT ______________________

GEORGE F. PAPPAS, Covington & Burling LLP, of Washington, DC, argued for plaintiffs-appellants. With him on the brief were JEFFREY B. ELIKAN and MICHELLE L. MORIN.

NICOLE W. STAFFORD, Wilson Sonsini Goodrich & Rosati, of Austin, Texas, argued for defendant-appellee. With her on the brief were ROBERT DELAFIELD; DAVID S. STEUER and MATTHEW A. ARGENTI, of Palo Alto, California. ______________________

THIS CAUSE having been heard and considered, it is

ORDERED and ADJUDGED:

PER CURIAM (RADER, Chief Judge, PLAGER and LOURIE, Circuit Judges).

AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT

April 9, 2012 /s/ Jan Horbaly Date Jan Horbaly Clerk